Authors : Lu L; 1] Cancer Theme, South Australian Health and Medical Research Institute (SAHMRI), Adelaide, South Australia, Australia [2] Discipline of Medicine, School of Medicine, University of Adelaide, Adelaide, South Australia, Australia.; Saunders VA

Subjects: ATP-Binding Cassette Transporters/ATP-Binding Cassette Transporters/ATP-Binding Cassette Transporters/*metabolism ; Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*pharmacokinetics ; Imidazoles/Imidazoles/Imidazoles/*pharmacokinetics

Source: Leukemia [Leukemia] 2015 Aug; Vol. 29 (8), pp. 1792-4. Date of Electronic Publication: 2015 Feb 13.Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Small molecule antibody targeting HLA class I inhibits myeloma cancer stem cells by repressing pluripotency-associated transcription factors.

Authors : Ikegame A; Department of Medicine and Bioregulatory Sciences, University of Tokushima Graduate School of Medical Sciences, Tokushima, Japan.; Ozaki S

Subjects: HLA Antigens/HLA Antigens/HLA Antigens/*immunology ; Multiple Myeloma/Multiple Myeloma/Multiple Myeloma/*immunology ; Multiple Myeloma/Multiple Myeloma/Multiple Myeloma/*therapy

Source: Leukemia [Leukemia] 2012 Sep; Vol. 26 (9), pp. 2124-34. Date of Electronic Publication: 2012 Mar 20.Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Report

Polymorphisms in xenobiotic transporters ABCB1, ABCG2, ABCC2, ABCC1, ABCC3 and multiple myeloma risk: a case-control study in the context of the International Multiple Myeloma rESEarch (IMMEnSE) consortium.

Authors : Martino A; Campa D; Buda G

Subjects: ATP Binding Cassette Transporter, Subfamily B, Member 1/ATP Binding Cassette Transporter, Subfamily B, Member 1/ATP Binding Cassette Transporter, Subfamily B, Member 1/*genetics ; ATP-Binding Cassette Transporters/ATP-Binding Cassette Transporters/ATP-Binding Cassette Transporters/*genetics ; Multidrug Resistance-Associated Proteins/Multidrug Resistance-Associated Proteins/Multidrug Resistance-Associated Proteins/*genetics

Source: Leukemia [Leukemia] 2012 Jun; Vol. 26 (6), pp. 1419-22. Date of Electronic Publication: 2011 Dec 20.Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Selective elimination of a chemoresistant side population of B-CLL cells by cytotoxic T lymphocytes in subjects receiving an autologous hCD40L/IL-2 tumor vaccine.

Authors : Foster AE; Center for Cell and Gene Therapy, Baylor College of Medicine, The Methodist Hospital and Texas Children's Hospital, Houston, TX 77030, USA. ; Okur FV

Subjects: CD40 Ligand/CD40 Ligand/CD40 Ligand/*immunology ; Cancer Vaccines/Cancer Vaccines/Cancer Vaccines/*immunology ; Leukemia, Lymphocytic, Chronic, B-Cell/Leukemia, Lymphocytic, Chronic, B-Cell/Leukemia, Lymphocytic, Chronic, B-Cell/*therapy

Source: Leukemia [Leukemia] 2010 Mar; Vol. 24 (3), pp. 563-72. Date of Electronic Publication: 2010 Jan 14.Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Nilotinib concentration in cell lines and primary CD34(+) chronic myeloid leukemia cells is not mediated by active uptake or efflux by major drug transporters.

Authors : Davies A; Department of Haematology, Royal Liverpool University Hospital, Liverpool, UK.; Jordanides NE

Subjects: Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/drug therapy ; Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/metabolism ; Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/pathology

Source: Leukemia [Leukemia] 2009 Nov; Vol. 23 (11), pp. 1999-2006. Date of Electronic Publication: 2009 Aug 27.Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Editorial & Opinion

Amonafide L-malate is not a substrate for multidrug resistance proteins in secondary acute myeloid leukemia.

Authors : Burcu M; O'Loughlin KL; Ford LA

Subjects: Drug Resistance, Multiple*; ATP Binding Cassette Transporter, Subfamily B, Member 1/ATP Binding Cassette Transporter, Subfamily B, Member 1/ATP Binding Cassette Transporter, Subfamily B, Member 1/*metabolism ; ATP-Binding Cassette Transporters/ATP-Binding Cassette Transporters/ATP-Binding Cassette Transporters/*metabolism

Source: Leukemia [Leukemia] 2008 Nov; Vol. 22 (11), pp. 2110-5. Date of Electronic Publication: 2008 Apr 17.Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Report

Evidence for the interaction of imatinib at the transport-substrate site(s) of the multidrug-resistance-linked ABC drug transporters ABCB1 (P-glycoprotein) and ABCG2.

Authors : Shukla S; Sauna ZE; Ambudkar SV

Subjects: ATP Binding Cassette Transporter, Subfamily B, Member 1/ATP Binding Cassette Transporter, Subfamily B, Member 1/ATP Binding Cassette Transporter, Subfamily B, Member 1/*metabolism ; ATP-Binding Cassette Transporters/ATP-Binding Cassette Transporters/ATP-Binding Cassette Transporters/*metabolism ; Neoplasm Proteins/Neoplasm Proteins/Neoplasm Proteins/*metabolism

Source: Leukemia [Leukemia] 2008 Feb; Vol. 22 (2), pp. 445-7. Date of Electronic Publication: 2007 Aug 09.Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Imatinib mesylate and nilotinib (AMN107) exhibit high-affinity interaction with ABCG2 on primitive hematopoietic stem cells.

Authors : Brendel C; Department of Hematology, Oncology and Immunology, Philipps-University Marburg, Baldingerstrasse, Marburg, Germany. ; Scharenberg C

Subjects: Drug Resistance, Neoplasm* ; Hematopoietic Stem Cells*; ATP-Binding Cassette Transporters/ATP-Binding Cassette Transporters/ATP-Binding Cassette Transporters/*antagonists & inhibitors

Source: Leukemia [Leukemia] 2007 Jun; Vol. 21 (6), pp. 1267-75. Date of Electronic Publication: 2007 Mar 22.Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

ABC transporters and drug resistance in leukemia: was P-gp nothing but the first head of the Hydra?

Authors : Steinbach D; Pediatrics, University Children's Hospital, Ulm, Germany. ; Legrand O

Subjects: Drug Resistance*; ATP Binding Cassette Transporter, Subfamily B, Member 1/ATP Binding Cassette Transporter, Subfamily B, Member 1/ATP Binding Cassette Transporter, Subfamily B, Member 1/*physiology ; ATP-Binding Cassette Transporters/ATP-Binding Cassette Transporters/ATP-Binding Cassette Transporters/*physiology

Source: Leukemia [Leukemia] 2007 Jun; Vol. 21 (6), pp. 1172-6. Date of Electronic Publication: 2007 Apr 12.Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Report

Breast cancer resistance protein (BCRP/ABCG2) does not confer resistance to gemtuzumab ozogamicin and calicheamicin-gamma1 in acute myeloid leukemia cells.

Authors : Walter RB; Raden BW; Thompson J

Subjects: ATP-Binding Cassette Transporters/ATP-Binding Cassette Transporters/ATP-Binding Cassette Transporters/*metabolism ; Aminoglycosides/Aminoglycosides/Aminoglycosides/*therapeutic use ; Antibiotics, Antineoplastic/Antibiotics, Antineoplastic/Antibiotics, Antineoplastic/*therapeutic use

Source: Leukemia [Leukemia] 2004 Nov; Vol. 18 (11), pp. 1914-7.Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print Cited Medium: Print

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

نتائج البحث

فلترة النتائج

Ponatinib is not transported by ABCB1, ABCG2 or OCT-1 in CML cells.

Small molecule antibody targeting HLA class I inhibits myeloma cancer stem cells by repressing pluripotency-associated transcription factors.

Polymorphisms in xenobiotic transporters ABCB1, ABCG2, ABCC2, ABCC1, ABCC3 and multiple myeloma risk: a case-control study in the context of the International Multiple Myeloma rESEarch (IMMEnSE) consortium.

Selective elimination of a chemoresistant side population of B-CLL cells by cytotoxic T lymphocytes in subjects receiving an autologous hCD40L/IL-2 tumor vaccine.

Nilotinib concentration in cell lines and primary CD34(+) chronic myeloid leukemia cells is not mediated by active uptake or efflux by major drug transporters.

Amonafide L-malate is not a substrate for multidrug resistance proteins in secondary acute myeloid leukemia.

Evidence for the interaction of imatinib at the transport-substrate site(s) of the multidrug-resistance-linked ABC drug transporters ABCB1 (P-glycoprotein) and ABCG2.

Imatinib mesylate and nilotinib (AMN107) exhibit high-affinity interaction with ABCG2 on primitive hematopoietic stem cells.

ABC transporters and drug resistance in leukemia: was P-gp nothing but the first head of the Hydra?

Breast cancer resistance protein (BCRP/ABCG2) does not confer resistance to gemtuzumab ozogamicin and calicheamicin-gamma1 in acute myeloid leukemia cells.

اتصل بنا

اتبع